Safety results of 50% enrollment from a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of repository corticotropin injection in patients with systemic lupus erythematosus despite moderate-dose corticosteroid use

Category Primary study
ConferenceArthritis and Rheumatology
Year 2019
This article has no abstract
Epistemonikos ID: 9383ee501ccafbda4af57652fedb7e4e9c4e72d2
First added on: Apr 30, 2026